# WhiteGlove Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/whiteglove-health

- Industry: Healthcare
- Headquarters: Austin, US
- Website: www.whiteglove.com
- Total disclosed funding: $53M
- Latest round: Series C (Jun 13, 2014)
- Investors on record: 4

## About

WhiteGlove Health is a healthcare service provider focusing on in-home medical care, ensuring patients receive quality health services tailored to their needs.WhiteGlove Health operates as a healthcare service company that delivers in-home medical services. Founded by Dean Thurman, Jeff Grail, and Mike Thurman, the company is headquartered in Austin, US. It raised USD 1.75 mn in a funding round on June 27, 2014, indicating investor interest in its innovative approach to healthcare delivery.WhiteGlove Health specializes in providing in-home medical services, offering a range of healthcare solutions designed for patient convenience. Their offerings include comprehensive care management and telehealth services, ensuring patients receive tailored medical attention from qualified professionals. This model allows for personalized care while maintaining a focus on patient engagement.WhiteGlove Health generates revenue through a service-based model that aligns with patient needs, providing billing options for in-home healthcare services. This approach enables the company to cater to diverse patient demographics, focusing on accessibility and quality of care in the healthcare market.WhiteGlove Health plans to expand its service offerings with new telehealth solutions aimed at increasing convenience for patients. The recent funding of USD 1.75 mn will support the development of these services and assist in entering new markets across the US. The company aims to enhance its healthcare solutions by 2025, focusing on regions with a growing demand for in-home healthcare services.

## Funding rounds

- Series C, Jun 13, 2014, $15M — Biomark Capital, HQ Investments, Enhanced Equity Funds
- Series B, Feb 1, 2014, $3.8M — Biomark Capital, HQ Investments, Enhanced Equity Funds
- Series A, May 30, 2013, $1.3M — Biomark Capital, HQ Investments, Enhanced Equity Funds
- Series E, Apr 2, 2012, $13M — Biomark Capital, HQ Investments, Enhanced Equity Funds
- Series D, Feb 22, 2011, $13M — Enhanced Equity Funds
- Series C, Mar 8, 2010, $7.7M — Hidden Lion Partners

## Investors

- Hidden Lion Partners (https://capitalatlas.ai/funds/hidden-lion-partners) — Series C
- Enhanced Equity Funds (https://capitalatlas.ai/funds/enhanced-equity-funds) — Series D, Series E, Series A, Series B, Series C
- Biomark Capital (https://capitalatlas.ai/funds/biomark-capital) — Series E, Series A, Series B, Series C
- HQ Investments — Series E, Series A, Series B, Series C